Literature DB >> 33330879

Factors associated with clinical severity in Emergency Department patients presenting with symptomatic SARS-CoV-2 infection.

Sophia Newton, Benjamin Zollinger, Jincong Freeman, Seamus Moran, Alexandra Helfand, Kayla Authelet, Matthew McHarg, Nataly Montano Vargas, Robert Shesser, Joanna Cohen, Derek Cummings, Yan Ma, Andrew C Meltzer.   

Abstract

OBJECTIVE: To measure the association of race, ethnicity, comorbidities, and insurance status with need for hospitalization of symptomatic Emergency Department (ED) patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
METHODS: This study is a retrospective case-series of symptomatic patients presenting to a single ED with laboratory-confirmed SARS-CoV-2 infection from March 12-August 9, 2020. We collected patient-level information regarding demographics, public insurance status (Medicare or Medicaid), comorbidities, level of care, and mortality using a structured chart review. We compared demographics and comorbidities of patients who were (1) able to convalesce at home, (2) required admission to general medical service, (3) required admission to intensive care unit (ICU), or (4) died within 30 days of the index visit. Multivariable logistic regression analyses were performed to report adjusted odds ratios (aOR) and the associated 95% confidence intervals (95% CI) with hospital admission versus ED discharge home.
RESULTS: In total, 993 patients who presented to the ED with symptoms were included in the analysis with 370 (37.3%) patients requiring hospital admission and 70 (7.1%) patients requiring ICU care. Patients requiring admission were more likely to be Black or African American, to be Hispanic or Latino, or to have public insurance (either Medicaid or Medicare.) On multivariable logistic regression analysis comparing which patients required hospital admission, African-American race (aOR 1.4, 95% CI 0.7-2.8) and Hispanic ethnicity (aOR 1.1, 95% CI 0.5-2.0) were not associated with need for admission but, public insurance (Medicaid: aOR 3.4, 95% CI 2.2-5.4; Medicare: aOR 2.6, 95% CI 1.2-5.3; Medicaid and Medicare: aOR 3.6 95% CI 2.1-6.2) and the presence of hypertension (aOR 1.8, 95% CI 1.2-2.7), diabetes (aOR 1.6, 95% CI 1.1-2.5), obesity (aOR 1.7, 95% CI 1.1-2.5), heart failure (aOR 3.9, 95% CI 1.4-11.2), and hyperlipidemia (aOR 1.8, 95% CI 1.2-2.9) were identified as independent predictors of hospital admission.
CONCLUSION: Comorbidities and public insurance are predictors of more severe illness for patients with SARS-CoV-2. This study suggests that the disparities in severity seen in COVID-19 among African Americans and Hispanics are likely to be closely related to low socioeconomic status and chronic health conditions and do not reflect an independent predisposition to disease severity.

Entities:  

Year:  2020        PMID: 33330879      PMCID: PMC7743088          DOI: 10.1101/2020.12.08.20246017

Source DB:  PubMed          Journal:  medRxiv


  8 in total

1.  Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.

Authors:  J Nicholas Bodor; Jessica R Bauman; Elizabeth A Handorf; Eric A Ross; Margie L Clapper; Joseph Treat
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-16       Impact factor: 4.322

2.  A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US.

Authors:  Wenhui Wei; Sumathi Sivapalasingam; Scott Mellis; Gregory P Geba; Jessica J Jalbert
Journal:  Adv Ther       Date:  2021-05-07       Impact factor: 3.845

3.  Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients.

Authors:  Alberto Polimeni; Isabella Leo; Carmen Spaccarotella; Annalisa Mongiardo; Sabato Sorrentino; Jolanda Sabatino; Salvatore De Rosa; Ciro Indolfi
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 4.  Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review.

Authors:  T Piticchio; R Le Moli; D Tumino; F Frasca
Journal:  J Endocrinol Invest       Date:  2021-02-13       Impact factor: 4.256

5.  Challenge in diagnosis of COVID-19 in hemodialysis patient: a case report and brief review of the literature.

Authors:  Rizky Andhika; Afiatin Makmun; Yovita Hartantri; Indra Wijaya; Ian Huang
Journal:  CEN Case Rep       Date:  2021-01-16

6.  Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data.

Authors:  Ani John; Baiyu Yang; Roma Shah
Journal:  Adv Ther       Date:  2021-02-04       Impact factor: 3.845

7.  Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Authors:  Katja Weisel; Thomas Martin; Amrita Krishnan; Sundar Jagannath; Anil Londhe; Sandhya Nair; Joris Diels; Martin Vogel; Jordan M Schecter; Arnob Banerjee; Jesus G Berdeja; Tonia Nesheiwat; Ashraf Garrett; Keqin Qi; Satish Valluri; Saad Z Usmani; Kwee Yong
Journal:  Clin Drug Investig       Date:  2021-11-25       Impact factor: 2.859

8.  SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy.

Authors:  Maria Teresa Sandri; Elena Azzolini; Valter Torri; Sara Carloni; Chiara Pozzi; Michela Salvatici; Michele Tedeschi; Massimo Castoldi; Alberto Mantovani; Maria Rescigno
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.